Lisata Therapeuti…
USUSDLisata Therapeutics Inc. (LSE:0HS8) — Biotechnology: Pharmaceutical Preparations. Numărul de burse pe care se tranzacționează acțiunile companiei: 2. Pe această pagină — preț și grafic, dividende, principalii deținători și istoricul numărului de acțiuni.
Despre companie
- Site web
- caladrius.com
- Sector
- Health Care · Biotechnology: Pharmaceutical Preparations
- Sediu central
- New York City, United States
- Angajați
- 21
- Fondată
- 2006
- Acțiuni în circulație
- 9.01 mil. la 2026-08-06
- Free float
- 6.65 mil.
- Capitalizare de piață
- 15.56 mil. USD
- Insideri
- 22.26%
- Investitori instituționali
- 13.41%
- Industrie (SIC)
- Pharmaceutical Preparations
- ISIN
- US1280583022
- LEI
- 5493002287F62M3EGQ04
Descriere
Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product is certepetide, which is in Phase 2 clinical studies for the treatment of solid tumors, such as metastatic pancreatic ductal adenocarcinoma, cholangiocarcinoma, appendiceal cancer, and colon cancer and glioblastoma multiforme in combination with range of anti-cancer regimens. Lisata Therapeutics, Inc. was formerly known as Caladrius Biosciences, Inc. and changed its name to Lisata Therapeutics, Inc. in September 2022. The company was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.
Dividende
Nu s-au găsit plăți de dividende (verificat 08.10.2026). Probabil că societatea nu plătește dividende.
Știri din această săptămână
Încă nu există știri de pe site-ul companiei.
Cei mai mari acționari
| Deținător | Participație | Acțiuni | Data raportului |
|---|---|---|---|
| Deeter Investments Llp | 4.04% | 364 479 | 2026-03-31 |
| MAZZO DAVID J (Officer a… | ≈3.46% | 311 890 | 2026-01-09 |
| Vanguard Capital Managem… | 3.09% | 278 837 | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.12% | 191 371 | 2026-06-30 |
| Yakira Capital Managemen… | 1.54% | 138 561 | 2026-06-30 |
| CSS LLC | 1.23% | 110 422 | 2026-06-30 |
| AZAB MOHAMMAD (Director) | ≈1.16% | 104 925 | 2026-01-09 |
| KLOSK STEVEN MARK (Direc… | ≈1.06% | 95 815 | 2026-01-09 |
| BROWN GREGORY B (Directo… | ≈1.06% | 95 659 | 2026-01-09 |
| FLOWERS CYNTHIA LOUISE (… | ≈1.06% | 95 446 | 2026-01-09 |
| BUCK KRISTEN K (Officer) | ≈1.04% | 93 462 | 2026-01-09 |
| HENSON HEIDI (Director) | ≈0.95% | 85 725 | 2026-01-09 |
| Deltec Asset Management… | 0.92% | 83 197 | 2026-06-30 |
| Rangeley Capital, LLC | 0.9% | 81 000 | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 0.89% | 80 444 | 2026-06-30 |
| Geode Capital Management… | 0.81% | 72 632 | 2026-06-30 |
| Virtu Financial LLC | 0.65% | 58 782 | 2026-06-30 |
| Blackrock Inc. | 0.61% | 54 857 | 2026-06-30 |
| Vanguard Fiduciary Trust… | 0.54% | 48 964 | 2026-06-30 |
| Fidelity Concord Street… | 0.42% | 38 275 | 2026-07-31 |
| IMAM TARIQ (General Coun… | ≈0.4% | 36 078 | 2026-01-09 |
| NISCO JAMES (Officer) | ≈0.36% | 32 311 | 2026-01-09 |
| Fidelity Concord Street… | 0.12% | 10 373 | 2026-07-31 |
| VANGUARD VALLEY FORGE FU… | 0.08% | 7 022 | 2026-06-30 |
| Fidelity Concord Street… | 0.05% | 4 427 | 2026-07-31 |
| Fidelity Concord Street… | 0.05% | 4 379 | 2026-07-31 |
| DFA INVESTMENT DIMENSION… | 0.02% | 2 185 | 2026-07-31 |
| Dimensional ETF Trust-Di… | 0% | 100 | 2026-07-31 |
| Dimensional ETF Trust-Di… | 0% | 8 | 2026-07-31 |
